Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Ceapro Inc > CZO's PGX-OBG and PGX-YBG
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(11)
•••
Post by stockfyon Jan 20, 2021 5:15pm
147 Views
Post# 32340285

CZO's PGX-OBG and PGX-YBG

CZO's PGX-OBG and PGX-YBG
Let's sum it up:

CZO's PGX oat beta glucan: This is in a human clinical trial under the influencial Dr. Jean Claude Tardif at the Montreal Heart Institute. Patients are being enrolled and randomized and results are expected this year. PGX OBG is for the cholesterol reducing pill and a functional drink, facts below:

https://www.ceapro.com/nutraceuticals/oat-beta-glucan

 
CZO's PGX yeast beta glucan: The Canadian Government has provided funding towards mass production and a clinical trial. CZO collaborates with McMaster, a university that ranks in the top 1% of universities in the world.This PGX-YBG will be tested as a potential inhalable therapeutic for COVID-19 and other fibrotic end-point diseases of the lung, facts below:

https://www.globenewswire.com/news-release/2020/11/27/2135353/0/en/Ceapro-Inc-Reports-2020-Third-Quarter-and-Nine-Month-Financial-Results-and-Operational-Highlights.html


In the meantime, CZO is profitable, debt-free with a significant amount of cash and trades just about 8.5 times its 2020 EBITDA. 

 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities